| Bid price | 5.75 | Open price | 5.88 |
|---|---|---|---|
| Ask price | 6.00 | Prev close | 5.88 |
| High price | 5.93 | Spread | 4.17% |
| Low price | 5.75 | Volume | 65,910 |
Register now for FREE live Xenetic BioSciences share prices, Xenetic BioSciences stock quotes, charts, trades and FREE Xenetic BioSciences company fundamentals, market news and much much more. Why not upgrade to a premium service and get Xenetic BioSciences Level 2 Data, indepth research tools and investor commentary for Xenetic BioSciences (XEN) and other London Stock Exchange equities.
Register now for FREE Xenetic BioSciences share price charts
| Name | Xenetic BioSciences | Epic | XEN |
|---|---|---|---|
| Activites | Develops drug delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology | Reuters | XEN.L |
| ISIN | GB00B08NWV55 | Google Finance | LON:XEN |
| Share Price (p) | 5.88 | Prev. Share Price (p) | 5.88 |
|---|---|---|---|
| Shares in Issue (m) | 408 | Market Cap (£m) | 24 |
| PE Ratio (x) | -11.94 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -1.00 | PEG |
Register now for FREE Xenetic BioSciences company fundamentals
Xenetic Biosciences announces that Dr Henry Hoppe has been appointed as Vice President of Drug Development for the Company. Dr Hoppe is a leading biotechnology drug development executive with over 20 years' experience in recombinant protein, monoclonal antibody and stem cell expression for...
/* */ RNS Number : 2305D Xenetic Biosciences PLC 14 May 2012 14 May 2012 Xenetic Biosciences plc ('Xenetic' or 'the Company') Appointment of Vice President for Drug Development Xenetic Biosciences plc (LSE: XEN.L), a...
/* */ RNS Number : 6288C Xenetic Biosciences PLC 03 May 2012 Xenetic Biosciences plc ('Xenetic' or 'the Company') Senior Appointment Xenetic Biosciences plc (LSE: XEN.L), a bio-pharmaceutical company...
More Xenetic BioSciences Company News >>
Register now for FREE Xenetic BioSciences company news
XEN is about to conclude two company-transforming deals: - with Synbio, a Russian sovereign-wealth backed company - with the similar sounding SymbioTech - a German biopharma
What's upt with this lot anyone know I hold a few shares from years ago not bothered but jut wonder if their is something going on
Any thoughts on xen. I know that they were £4.50ish a few years ago. I bought them a few months ago at 17p so they owe me a bit of money. Thanks mary
Register now for FREE Xenetic BioSciences share price discussions